Matter Bio is a longevity holding company focused on preserving genome integrity.

As we age, our genome is constantly being damaged by exogenous and endogenous sources.

Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss.

At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome. To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.